Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 265

1.

Examining effects of unit price on preference for reduced nicotine content cigarettes and smoking rate.

Davis DR, DeSarno MJ, Bergeria CL, Streck JM, Tidey JW, Sigmon SC, Heil SH, Gaalema DE, Stitzer ML, Higgins ST.

Prev Med. 2019 Nov;128:105823. doi: 10.1016/j.ypmed.2019.105823. Epub 2019 Aug 27.

PMID:
31470023
2.

Enhancing patient navigation with contingent financial incentives for substance use abatement in persons with HIV and substance use.

Stitzer ML, Gukasyan N, Matheson T, Sorensen JL, Feaster DJ, Duan R, Gooden L, Del Rio C, Metsch LR.

Psychol Addict Behav. 2019 Aug 22. doi: 10.1037/adb0000504. [Epub ahead of print]

PMID:
31436447
3.

Potential Moderating Effects of Sex/Gender on the Acute Relative Reinforcing and Subjective Effects of Reduced Nicotine Content Cigarettes in Vulnerable Populations.

Streck JM, Davis DR, Pang RD, Sigmon SC, Bunn JY, Bergeria CL, Tidey JW, Heil SH, Gaalema DE, Hughes JR, Stitzer ML, Reed E, Higgins ST.

Nicotine Tob Res. 2019 Jun 19. pii: ntz098. doi: 10.1093/ntr/ntz098. [Epub ahead of print]

PMID:
31225625
4.

Evaluating the utility of the modified cigarette evaluation questionnaire and cigarette purchase task for predicting acute relative reinforcing efficacy of cigarettes varying in nicotine content.

Bergeria CL, Heil SH, Davis DR, Streck JM, Sigmon SC, Bunn JY, Tidey JW, Arger CA, Reed DD, Gallagher T, Hughes JR, Gaalema DE, Stitzer ML, Higgins ST.

Drug Alcohol Depend. 2019 Apr 1;197:56-64. doi: 10.1016/j.drugalcdep.2019.01.004. Epub 2019 Feb 13.

PMID:
30776572
5.

Response to reduced nicotine content cigarettes among smokers with chronic health conditions.

Streck JM, Bergeria CL, Parker MA, Davis DR, DeSarno M, Sigmon SC, Hughes JR, Gaalema DE, Heil SH, Tidey JW, Stitzer ML, Rothman M, Higgins ST.

Prev Med Rep. 2018 Oct 15;12:321-329. doi: 10.1016/j.pmedr.2018.10.001. eCollection 2018 Dec.

6.

Enhancing Patient Navigation with Contingent Incentives to Improve Healthcare Behaviors and Viral Load Suppression of Persons with HIV and Substance Use.

Stitzer ML, Hammond AS, Matheson T, Sorensen JL, Feaster DJ, Duan R, Gooden L, Del Rio C, Metsch LR.

AIDS Patient Care STDS. 2018 Jul;32(7):288-296. doi: 10.1089/apc.2018.0014. Epub 2018 Jun 8.

7.

The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration.

Schlienz NJ, Lee DC, Stitzer ML, Vandrey R.

Drug Alcohol Depend. 2018 Jun 1;187:254-260. doi: 10.1016/j.drugalcdep.2018.02.022. Epub 2018 Apr 17.

8.

Response to reduced nicotine content cigarettes among smokers differing in tobacco dependence severity.

Higgins ST, Bergeria CL, Davis DR, Streck JM, Villanti AC, Hughes JR, Sigmon SC, Tidey JW, Heil SH, Gaalema DE, Stitzer ML, Priest JS, Skelly JM, Reed DD, Bunn JY, Tromblee MA, Arger CA, Miller ME.

Prev Med. 2018 Dec;117:15-23. doi: 10.1016/j.ypmed.2018.04.010. Epub 2018 Apr 4.

9.

Preliminary validity of the modified Cigarette Evaluation Questionnaire in predicting the reinforcing effects of cigarettes that vary in nicotine content.

Arger CA, Heil SH, Sigmon SC, Tidey JW, Stitzer ML, Gaalema DE, Durand HJ, Bunn JY, Ruggieri EK, Higgins ST.

Exp Clin Psychopharmacol. 2017 Dec;25(6):473-478. doi: 10.1037/pha0000145.

10.

Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco Addiction.

Higgins ST, Heil SH, Sigmon SC, Tidey JW, Gaalema DE, Hughes JR, Stitzer ML, Durand H, Bunn JY, Priest JS, Arger CA, Miller ME, Bergeria CL, Davis DR, Streck JM, Reed DD, Skelly JM, Tursi L.

JAMA Psychiatry. 2017 Oct 1;74(10):1056-1064. doi: 10.1001/jamapsychiatry.2017.2355. Erratum in: JAMA Psychiatry. 2018 Dec 1;75(12):1304.

11.

Health care cost trajectories in the year prior to and following intake into Veterans Health Administration outpatient substance use disorders treatment.

Hagedorn HJ, Noorbaloochi S, Bangerter A, Stitzer ML, Kivlahan D.

J Subst Abuse Treat. 2017 Aug;79:46-52. doi: 10.1016/j.jsat.2017.05.013. Epub 2017 May 25.

PMID:
28673526
12.

Prescription opioids: New perspectives and research on their role in chronic pain management and addiction.

Stitzer ML, Schwartz RP, Bigelow GE.

Drug Alcohol Depend. 2017 Apr 1;173 Suppl 1:S1-S3. doi: 10.1016/j.drugalcdep.2016.11.018. No abstract available.

13.

Response to varying the nicotine content of cigarettes in vulnerable populations: an initial experimental examination of acute effects.

Higgins ST, Heil SH, Sigmon SC, Tidey JW, Gaalema DE, Stitzer ML, Durand H, Bunn JY, Priest JS, Arger CA, Miller ME, Bergeria CL, Davis DR, Streck JM, Zvorsky I, Redner R, Vandrey R, Pacek LR.

Psychopharmacology (Berl). 2017 Jan;234(1):89-98. doi: 10.1007/s00213-016-4438-z. Epub 2016 Oct 6.

14.

Contingency Management Interventions for HIV, Tuberculosis, and Hepatitis Control Among Individuals With Substance Use Disorders: A Systematized Review.

Herrmann ES, Matusiewicz AK, Stitzer ML, Higgins ST, Sigmon SC, Heil SH.

J Subst Abuse Treat. 2017 Jan;72:117-125. doi: 10.1016/j.jsat.2016.06.009. Epub 2016 Jun 24. Review.

15.

Randomized Trial of Reduced-Nicotine Standards for Cigarettes.

Donny EC, Denlinger RL, Tidey JW, Koopmeiners JS, Benowitz NL, Vandrey RG, al'Absi M, Carmella SG, Cinciripini PM, Dermody SS, Drobes DJ, Hecht SS, Jensen J, Lane T, Le CT, McClernon FJ, Montoya ID, Murphy SE, Robinson JD, Stitzer ML, Strasser AA, Tindle H, Hatsukami DK.

N Engl J Med. 2015 Oct;373(14):1340-9. doi: 10.1056/NEJMsa1502403.

16.

The Use of Technology in Participant Tracking and Study Retention: Lessons Learned From a Clinical Trials Network Study.

Mitchell SG, Schwartz RP, Alvanzo AA, Weisman MS, Kyle TL, Turrigiano EM, Gibson ML, Perez L, McClure EA, Clingerman S, Froias A, Shandera DR, Walker R, Babcock DL, Bailey GL, Miele GM, Kunkel LE, Norton M, Stitzer ML.

Subst Abus. 2015;36(4):420-6. doi: 10.1080/08897077.2014.992565. Epub 2015 Feb 11.

17.

Cigarette Smoking During Substance Use Disorder Treatment: Secondary Outcomes from a National Drug Abuse Treatment Clinical Trials Network study.

McClure EA, Campbell AN, Pavlicova M, Hu M, Winhusen T, Vandrey RG, Ruglass LM, Covey LS, Stitzer ML, Kyle TL, Nunes EV.

J Subst Abuse Treat. 2015 Jun;53:39-46. doi: 10.1016/j.jsat.2014.12.007. Epub 2014 Dec 30.

18.

A therapeutic workplace for the long-term treatment of drug addiction and unemployment: eight-year outcomes of a social business intervention.

Aklin WM, Wong CJ, Hampton J, Svikis DS, Stitzer ML, Bigelow GE, Silverman K.

J Subst Abuse Treat. 2014 Nov-Dec;47(5):329-38. doi: 10.1016/j.jsat.2014.06.013. Epub 2014 Jul 12.

19.

A randomized study of contingency management and spirometric lung age for motivating smoking cessation among injection drug users.

Drummond MB, Astemborski J, Lambert AA, Goldberg S, Stitzer ML, Merlo CA, Rand CS, Wise RA, Kirk GD.

BMC Public Health. 2014 Jul 28;14:761. doi: 10.1186/1471-2458-14-761.

20.

An implementation-focused process evaluation of an incentive intervention effectiveness trial in substance use disorders clinics at two Veterans Health Administration medical centers.

Hagedorn HJ, Stetler CB, Bangerter A, Noorbaloochi S, Stitzer ML, Kivlahan D.

Addict Sci Clin Pract. 2014 Jul 9;9:12. doi: 10.1186/1940-0640-9-12.

21.

Cognitive performance in methadone maintenance patients: effects of time relative to dosing and maintenance dose level.

Rass O, Kleykamp BA, Vandrey RG, Bigelow GE, Leoutsakos JM, Stitzer ML, Strain EC, Copersino ML, Mintzer MZ.

Exp Clin Psychopharmacol. 2014 Jun;22(3):248-256. doi: 10.1037/a0035712. Epub 2014 Feb 17.

22.

Promoting careers in academic research to psychiatry residents.

Posporelis S, Sawa A, Smith GS, Stitzer ML, Lyketsos CG, Chisolm MS.

Acad Psychiatry. 2014 Apr;38(2):185-90. doi: 10.1007/s40596-014-0037-7. Epub 2014 Feb 5.

23.

Characterizing smoking, cessation services, and quit interest across outpatient substance abuse treatment modalities.

McClure EA, Acquavita SP, Dunn KE, Stoller KB, Stitzer ML.

J Subst Abuse Treat. 2014 Feb;46(2):194-201. doi: 10.1016/j.jsat.2013.07.009. Epub 2013 Aug 27.

24.

Buprenorphine and medication management in a community corrections population: a pilot study.

Cropsey KL, Lane PS, Perkins AC, Clark CB, Hardy S, McCullumsmith C, Stitzer ML.

J Addict Med. 2013 May-Jun;7(3):210-5. doi: 10.1097/ADM.0b013e31828e6b21.

PMID:
23609213
25.

Rewarding early abstinence in Veterans Health Administration addiction clinics.

Hagedorn HJ, Noorbaloochi S, Simon AB, Bangerter A, Stitzer ML, Stetler CB, Kivlahan D.

J Subst Abuse Treat. 2013 Jul;45(1):109-17. doi: 10.1016/j.jsat.2013.01.006. Epub 2013 Feb 28.

PMID:
23453480
26.

Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?

Stitzer ML.

Addiction. 2013 Feb;108(2):249-50. doi: 10.1111/j.1360-0443.2012.03883.x. No abstract available.

PMID:
23331877
27.

Utilization of communication technology by patients enrolled in substance abuse treatment.

McClure EA, Acquavita SP, Harding E, Stitzer ML.

Drug Alcohol Depend. 2013 Apr 1;129(1-2):145-50. doi: 10.1016/j.drugalcdep.2012.10.003. Epub 2012 Oct 26.

28.

HIV rapid testing in drug treatment: comparison across treatment modalities.

Schwartz RP, Stitzer ML, Feaster DJ, Korthuis PT, Alvanzo AA, Winhusen TM, Donnard L, Snead N, Metsch LR.

J Subst Abuse Treat. 2013 Apr;44(4):369-74. doi: 10.1016/j.jsat.2012.08.219. Epub 2012 Sep 27.

29.

The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users.

Vandrey R, Stitzer ML, Mintzer MZ, Huestis MA, Murray JA, Lee D.

Drug Alcohol Depend. 2013 Feb 1;128(1-2):64-70. doi: 10.1016/j.drugalcdep.2012.08.001. Epub 2012 Aug 22.

30.

Adolescent Substance Abuse and Mental Health: Problem Co-Occurrence and Access to Services.

Winstanley EL, Steinwachs DM, Stitzer ML, Fishman MJ.

J Child Adolesc Subst Abuse. 2012 Jul 1;21(4):310-322.

31.

Effects of varenicline on abstinence and smoking reward following a programmed lapse.

McClure EA, Vandrey RG, Johnson MW, Stitzer ML.

Nicotine Tob Res. 2013 Jan;15(1):139-48. doi: 10.1093/ntr/nts101. Epub 2012 May 9.

32.

Is exposure to an effective contingency management intervention associated with more positive provider beliefs?

Kirby KC, Carpenedo CM, Stitzer ML, Dugosh KL, Petry NM, Roll JM, Saladin ME, Cohen AJ, Hamilton J, Reese K, Sillo GR, Stabile PQ, Sterling RC.

J Subst Abuse Treat. 2012 Jun;42(4):356-65. doi: 10.1016/j.jsat.2011.09.004. Epub 2011 Nov 23.

33.

Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network.

Campbell AN, Nunes EV, Miele GM, Matthews A, Polsky D, Ghitza UE, Turrigiano E, Bailey GL, VanVeldhuisen P, Chapdelaine R, Froias A, Stitzer ML, Carroll KM, Winhusen T, Clingerman S, Perez L, McClure E, Goldman B, Crowell AR.

Contemp Clin Trials. 2012 Mar;33(2):386-95. doi: 10.1016/j.cct.2011.11.001. Epub 2011 Nov 9.

34.

Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth.

Subramaniam GA, Warden D, Minhajuddin A, Fishman MJ, Stitzer ML, Adinoff B, Trivedi M, Weiss R, Potter J, Poole SA, Woody GE.

J Am Acad Child Adolesc Psychiatry. 2011 Nov;50(11):1120-8. doi: 10.1016/j.jaac.2011.07.010.

35.

Identifying provider beliefs related to contingency management adoption using the contingency management beliefs questionnaire.

Rash CJ, Petry NM, Kirby KC, Martino S, Roll J, Stitzer ML.

Drug Alcohol Depend. 2012 Mar 1;121(3):205-12. doi: 10.1016/j.drugalcdep.2011.08.027. Epub 2011 Sep 16.

36.

Characterizing smoking topography of cannabis in heavy users.

McClure EA, Stitzer ML, Vandrey R.

Psychopharmacology (Berl). 2012 Mar;220(2):309-18. doi: 10.1007/s00213-011-2480-4. Epub 2011 Sep 16.

37.

Ten take home lessons from the first 10 years of the CTN and 10 recommendations for the future.

Carroll KM, Ball SA, Jackson R, Martino S, Petry NM, Stitzer ML, Wells EA, Weiss RD.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):275-82. doi: 10.3109/00952990.2011.596978.

38.

Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China.

Hser YI, Li J, Jiang H, Zhang R, Du J, Zhang C, Zhang B, Evans E, Wu F, Chang YJ, Peng C, Huang D, Stitzer ML, Roll J, Zhao M.

Addiction. 2011 Oct;106(10):1801-9. doi: 10.1111/j.1360-0443.2011.03490.x. Epub 2011 Jul 27.

39.

Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system.

Cropsey KL, Lane PS, Hale GJ, Jackson DO, Clark CB, Ingersoll KS, Islam MA, Stitzer ML.

Drug Alcohol Depend. 2011 Dec 15;119(3):172-8. doi: 10.1016/j.drugalcdep.2011.06.021. Epub 2011 Jul 23.

40.

Pay-for-performance in a community substance abuse clinic.

Vandrey R, Stitzer ML, Acquavita SP, Quinn-Stabile P.

J Subst Abuse Treat. 2011 Sep;41(2):193-200. doi: 10.1016/j.jsat.2011.03.001. Epub 2011 Apr 12.

41.

Impact of self-initiated pre-quit smoking reduction on cessation rates: results of a clinical trial of smoking cessation among female prisoners.

Cropsey KL, Jackson DO, Hale GJ, Carpenter MJ, Stitzer ML.

Addict Behav. 2011 Jan-Feb;36(1-2):73-8. doi: 10.1016/j.addbeh.2010.08.026.

42.

The impact of quitting smoking on weight among women prisoners participating in a smoking cessation intervention.

Cropsey KL, McClure LA, Jackson DO, Villalobos GC, Weaver MF, Stitzer ML.

Am J Public Health. 2010 Aug;100(8):1442-8. doi: 10.2105/AJPH.2009.172783. Epub 2010 Jun 17.

43.

Cross-validation of a new procedure for early screening of smoking cessation medications in humans.

Perkins KA, Lerman C, Fonte CA, Mercincavage M, Stitzer ML, Chengappa KN, Jain A.

Clin Pharmacol Ther. 2010 Jul;88(1):109-14. doi: 10.1038/clpt.2010.65. Epub 2010 May 19.

PMID:
20485335
44.

The added risk of opioid problem use among treatment-seeking youth with marijuana and/or alcohol problem use.

Subramaniam GA, Ives ML, Stitzer ML, Dennis ML.

Addiction. 2010 Apr;105(4):686-98. doi: 10.1111/j.1360-0443.2009.02829.x.

45.

Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network study.

Wu LT, Pan JJ, Blazer DG, Tai B, Stitzer ML, Woody GE.

J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S70-9. doi: 10.1016/j.jsat.2009.12.011.

46.

Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network.

Stitzer ML, Petry NM, Peirce J.

J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S61-9. doi: 10.1016/j.jsat.2009.12.010.

47.

Factors related to injection drug use among female prisoners.

Jackson DO, Cropsey KL, Weaver MF, Villalobos GC, Eldridge G, Stitzer ML.

Subst Use Misuse. 2010 Feb;45(3):368-83. doi: 10.3109/10826080903452454.

PMID:
20141453
48.

Abuse liability assessment of tobacco products including potential reduced exposure products.

Carter LP, Stitzer ML, Henningfield JE, O'Connor RJ, Cummings KM, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3241-62. doi: 10.1158/1055-9965.EPI-09-0948. Review.

49.

Drug users' adherence to a 6-month vaccination protocol: effects of motivational incentives.

Stitzer ML, Polk T, Bowles S, Kosten T.

Drug Alcohol Depend. 2010 Feb 1;107(1):76-9. doi: 10.1016/j.drugalcdep.2009.09.006. Epub 2009 Oct 13.

50.

Delay of smoking gratification as a laboratory model of relapse: effects of incentives for not smoking, and relationship with measures of executive function.

Mueller ET, Landes RD, Kowal BP, Yi R, Stitzer ML, Burnett CA, Bickel WK.

Behav Pharmacol. 2009 Sep;20(5-6):461-73. doi: 10.1097/FBP.0b013e3283305ec7.

Supplemental Content

Loading ...
Support Center